Credit Suisse Ag Ice Cure Medical Ltd. Transaction History

Credit Suisse Ag

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$2.01 - $3.31 $112,551 - $185,346	-55,996 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.73 - $8.7 $152,869 - $487,165	55,996 New	55,996 $52.5 Million

100K

Ticker ICCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,835,600
Market Cap $27.3M
Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.